Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
5-Amino-1MQ
Weight Management
Abarelix
Hormone Support
Acetyl Hexapeptide-3 (Argireline)
Cosmetic
Adipotide
Weight Management
Adrenomedullin
Healing & Recovery
Alexamorelin
Growth Hormone
Angiotensin (1-7)
Healing & Recovery
AOD-9604
Weight Management
Apelin-13
Healing & Recovery
ARA-290 (Cibinetide)
Healing & Recovery
Bestatin (Ubenimex)
Immune
BPC-157
Healing & Recovery
Buserelin
Hormone Support
Cagrilintide
Weight Management
CagriSema
Weight Management
Capromorelin
Growth Hormone
Cartalax
Anti-Aging
Cathelicidin (hCAP-18 / Synthetic Derivatives)
Immune
Cerebrolysin
Cognitive
Cerluten
Cognitive
Cetrorelix
Hormone Support
Chonluten
Immune
CJC-1295 (No DAC)
Growth Hormone
CJC-1295 with DAC
Growth Hormone
Cortexin
Cognitive
Crystagen
Immune
Daptomycin
Immune
Defensin (HBD-2)
Immune
Defensin (HBD-3)
Immune
Degarelix
Hormone Support
Dihexa
Cognitive
DSIP (Delta Sleep-Inducing Peptide)
Sleep & Recovery
Dulaglutide
Weight Management
Enalapril
Healing & Recovery
Epithalon
Anti-Aging
Exenatide
Weight Management
Fertirelin
Hormone Support
FOXO4-DRI
Anti-Aging
Ganirelix
Hormone Support
GHK-Cu (Copper Peptide)
Cosmetic
GHRH (1-29)
Growth Hormone
GHRP-2
Growth Hormone
GHRP-6 (Growth Hormone Releasing Peptide-6)
Growth Hormone
Glutathione
Anti-Aging
Gonadorelin (GnRH)
Hormone Support
Gramicidin
Immune
Hexarelin
Growth Hormone
Human Chorionic Gonadotropin (HCG)
Hormone Support
Human Growth Hormone (HGH)
Growth Hormone
IGF-1 LR3
Growth Hormone
Immunoxel (Dzherelo)
Immune
Imunofan
Immune
Intermedin (Adrenomedullin-2)
Healing & Recovery
Ipamorelin
Growth Hormone
Kisspeptin-10
Sexual Health
KPV (Alpha-MSH Fragment)
Healing & Recovery
Lactoferricin B
Immune
Larazotide
Healing & Recovery
Lentinan
Immune
Leuphasyl
Cosmetic
Leuprolide
Hormone Support
Liraglutide
Weight Management
Livagen
Anti-Aging
Lixisenatide
Weight Management
LL-37
Immune
Macimorelin
Growth Hormone
Magainin-2
Immune
Mazdutide
Weight Management
Melanotan-2
Cosmetic
MK-677 (Ibutamoren)
Growth Hormone
MOTS-c
Metabolic
Myristoyl Pentapeptide-17
Cosmetic
N-Acetyl Selank
Cognitive
N-Acetyl Semax Amidate
Cognitive
NAD+
Mitochondrial
Nafarelin
Hormone Support
Natriuretic Peptide (ANP)
Healing & Recovery
Nesiritide (BNP)
Healing & Recovery
Nisin
Immune
Noopept (Omberacetam)
Cognitive
Orforglipron
Weight Management
Ovagen
Anti-Aging
Oxytocin Acetate
Hormone Support
P21 (P021)
Cognitive
PACAP-38
Healing & Recovery
Palmitoyl Oligopeptide
Cosmetic
Palmitoyl Pentapeptide-4 (Matrixyl)
Cosmetic
Palmitoyl Tetrapeptide-7
Cosmetic
Palmitoyl Tripeptide-1
Cosmetic
Pancragen
Metabolic
PEG-MGF
Healing & Recovery
Pemvidutide
Weight Management
Pentadecapeptide (BPC Analog)
Healing & Recovery
Pidotimod
Immune
Pinealon
Cognitive
PNC-27
Immune
Polymyxin B
Immune
Pralmorelin (GHRP-2)
Growth Hormone
Pramlintide
Weight Management
Prostamax
Hormone Support
PT-141 (Bremelanotide)
Sexual Health
Relaxin-2 (Serelaxin)
Healing & Recovery
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Setmelanotide
Weight Management
SLU-PP-332
Metabolic
SM-130686
Growth Hormone
Snap-8
Cosmetic
SS-31 (Elamipretide)
Mitochondrial
Substance P Antagonists
Healing & Recovery
Survodutide
Weight Management
SYN-AKE
Cosmetic
Tabimorelin
Growth Hormone
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Testagen
Hormone Support
Thymalin
Immune
Thymopentin (TP-5)
Immune
Thymopoietin
Immune
Thymosin Alpha-1
Immune
Thymosin Beta-4
Healing & Recovery
Thymulin (FTS)
Immune
Thymulin Analog (PAT)
Healing & Recovery
Tirzepatide
Weight Management
Tripeptide-29
Cosmetic
Triptorelin
Hormone Support
Ularitide
Healing & Recovery
Urocortin
Healing & Recovery
Ventfort
Anti-Aging
Vesilute
Hormone Support
Vilon
Immune
VIP (Vasoactive Intestinal Peptide)
Healing & Recovery
Xenin-25
Metabolic
Ziconotide (Prialt)
Healing & Recovery
Total Peptides: 137
Back to Home

Kisspeptin-10

A powerful reproductive hormone regulator that acts like the master switch for your body's fertility system—triggering the release of hormones that control everything from ovulation to testosterone production.

Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards

Sexual HealthResearch compound

Suggested dose

50 – 200 mcg

Once dailyCycle: 4-6 weeksOnset: Rapid (hours to days)
~4 minutesHalf-life(IV); slightly longer subcutaneously
High when injected; lower intranasal but still effectiveBioavailability
1302.45 g/molMolecular weight
Moderate human trialsEvidence level

Compound profile

Kisspeptin-10 scientific & efficacy data

Sexual Health

Peptide profile

Hormone Activation9.4
Sexual Health8.9
Fertility Support9.2

Moderate human trials

Kisspeptin-10

50 mcg per injection · Once daily

Molecular formula

C63H83N17O14

Mol. weight
1302.45 g/mol
CAS number
374675-21-5
PubChem
25240297
Developed · 1996
Danny Welch, PhD (KISS1 gene); Takeshi Ohtaki et al. (peptide isolation)
Penn State University (gene discovery); Takeda Pharmaceutical Company (peptide characterization)

Amino acid sequence

Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 (YNWNSFGLRF-NH2)

Hormone Activation

Powerfully stimulates natural LH, FSH, and downstream sex hormone production through the body's own signaling cascade [6][7]

Sexual Health

Enhances brain activity in attraction and arousal centers, improving sexual desire at the neurological level [1][2]

Fertility Support

Triggers physiological hormone patterns that support reproduction while minimizing risks like OHSS in IVF [3][13]

Dosing

How much Kisspeptin-10 do I take?

50 – 200 mcg · subcutaneous

Subcutaneous

50 – 200 mcg

Covers all 4 documented dose levels · 2 administration routes · timing · dose-adjustment guidance.

Every documented dose level

PhaseDoseFrequencyRoute
Weeks 1-250 mcg per injectionOnce dailySubcutaneous
Weeks 4-6100 mcg per injectionOnce dailySubcutaneous
Weeks 4-6100-200 mcg per injectionOnce or twice dailySubcutaneous
Single administration1 mcg/kg bolusSingle bolus (research setting)Intravenous
Kisspeptin-10Once daily

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Suitability

Is Kisspeptin-10 right for me?

Best for fertility support and optimization & natural testosterone enhancement

Best for

Fertility and IVF Support

Kisspeptin is showing remarkable promise as a safer alternative to traditional IVF triggers. Unlike hCG, it dramatically reduces the risk of ovarian hyperstimulation syndrome (OHSS)—a potentially dangerous IVF complication. Studies show kisspeptin can mature eggs effectively while keeping ovarian volume 3x smaller than with hCG [3][13].

Natural Testosterone Optimization in Men

Rather than replacing your testosterone from outside (which shuts down natural production), kisspeptin tells your brain to make more. It stimulates LH release, which signals your testes to produce testosterone naturally. [6][7] This approach maintains fertility and testicular function—unlike exogenous testosterone [22].

Low Sexual Desire (Hypoactive Sexual Desire Disorder)

Clinical trials have shown kisspeptin enhances brain activity in regions involved in sexual arousal and attraction. In men with HSDD, it increased penile response by up to 56% and improved happiness about sex. In women, it modulated brain areas involved in sexual and attraction processing [1][2].

Hypothalamic Amenorrhea Recovery

For women who've lost their periods due to stress, low body weight, or over-exercise, kisspeptin can help restart the reproductive system. It acts on the hypothalamus to reinitiate GnRH pulsing—the first step in bringing periods back naturally [5][12].

Consider alternatives if

Testosterone enhancement without affecting fertilityGonadorelin, Enclomiphene, HCG
Sexual desire and arousal improvementPT-141 (Bremelanotide), MT-2 (Melanotan II)
Female fertility supportFSH injections, Clomiphene, Letrozole

Do not use if

You are pregnant or might become pregnant—kisspeptin powerfully affects reproductive hormonesYou have hormone-sensitive cancers (breast, prostate, ovarian, endometrial)You've had a serious allergic reaction to any peptideYou're under 18 unless being treated for delayed puberty under specialist supervisionYou're taking GnRH antagonists (they directly block kisspeptin's target) [17]

Use with caution if

You have cardiovascular conditions—kisspeptin can temporarily increase heart rate and blood pressureYou have polycystic ovary syndrome (PCOS)—response may be exaggeratedYou take blood pressure medications—monitor for additive effectsYou have a history of hot flashes or flushing disordersYou're on hormone replacement therapy—effects may be unpredictable

Not sure?

Compare Kisspeptin-10 with similar peptides to find the best fit for your goals.

Administration

How do I use Kisspeptin-10?

Subcutaneous injection · Intravenous injection

Route

Subcutaneous injection (just under the skin)—the most practical method for self-administration with good absorption

Best sites

Belly fat area (about 2 inches away from your belly button)Front or outer thigh (middle section)Back of the upper arm

Covers reconstitution · step-by-step technique · storage · a sample daily schedule.

Safety

Is Kisspeptin-10 safe?

3 common side effects · 1 serious

Kisspeptin has demonstrated an excellent safety profile across multiple clinical trials at Imperial College London and other research centers.

Studies involving healthy volunteers and patients with reproductive disorders have shown no serious adverse events. [5][13] The most common effects—flushing and feeling warm—are related to its mechanism of action and resolve quickly.

[15][20] Importantly, kisspeptin doesn't cause anxiety or negative psychological effects, which was confirmed in a study of 95 participants [4].

Safety data comes primarily from Phase 1-2 clinical trials conducted at major research institutions including Imperial College London. [13] Studies have included both men and women, healthy volunteers and patients with reproductive disorders like HSDD and hypothalamic amenorrhea.

[1][2][12] While the safety profile looks promising, long-term studies are still ongoing.

Less common

Temporary heart rate increaseDizziness

These typically resolve with continued use or dose adjustment.

Common side effects · experienced by some users

  • Flushing or warmth

    Temporary feeling of warmth or reddening of the skin, particularly in the face and chest. [20] This is related to kisspeptin's effects on the vascular system [15].

    Management: This typically resolves within 30-60 minutes. Stay hydrated and avoid hot environments immediately after injection. Consider evening dosing if bothersome.

  • Injection site reactions

    Mild redness, slight swelling, or minor irritation where you injected. Common with any subcutaneous injection.

    Management: Rotate injection sites between belly, thigh, and arm. Use proper technique with alcohol prep. Usually resolves within 24 hours.

  • Mild headache

    Some users report headaches, possibly related to the rapid hormonal changes kisspeptin triggers [19].

    Management: Stay well-hydrated before and after injection. These typically improve as your body adjusts over the first few days.

Stop and seek help if

  • Any signs of allergic reaction—stop immediately and seek medical help
  • Persistent flushing or overheating that doesn't improve with dose reduction [20]
  • Significant increases in blood pressure or heart rate
  • Worsening of any hormone-sensitive condition
  • Unexpected breast tissue changes in men (gynecomastia symptoms)
  • Your treatment protocol is complete or goals achieved

Kisspeptin-10 is a research compound, not an FDA-approved medication. Never start, stop, or change your dosing without guidance from a qualified healthcare provider. This information is for educational purposes only—not medical advice.

With other peptides

  • Safe:PT-141 (Bremelanotide) — Both affect sexual function through different pathways. Can be used together for enhanced sexual health benefits—space injections 30+ minutes apart.
  • Caution:Gonadorelin — Both stimulate GnRH/gonadotropin release. Using together may cause excessive hormonal stimulation. Generally not needed together as mechanisms overlap.
  • Safe:HCG — Can be combined in fertility protocols. HCG acts downstream of kisspeptin's effects. Commonly used together in IVF under medical supervision.
  • Safe:BPC-157 — No known interactions. Different mechanisms and targets. Safe to use together for different goals.

With medications

  • Caution:GnRH antagonists (Cetrorelix, Ganirelix) — These directly block the receptor that kisspeptin ultimately activates. Do not combine—they work against each other [17].
  • Caution:Testosterone replacement therapy — Exogenous testosterone suppresses LH release, which is what kisspeptin stimulates. Using together defeats the purpose of kisspeptin [22].
  • Safe:Blood pressure medications — Kisspeptin can temporarily affect blood pressure. Monitor more closely. Not necessarily dangerous but requires attention.
  • Safe:Fertility medications (Clomiphene, Letrozole) — Can be combined in fertility protocols. May have synergistic effects on hormone stimulation. Use under medical supervision.

With supplements

  • Safe:D-Aspartic Acid — Both aim to stimulate natural testosterone production. May have additive effects. Monitor for overstimulation.
  • Safe:Zinc supports testosterone production and is safe to combine. May enhance kisspeptin's hormonal effects.
  • Safe:Ashwagandha — Safe to combine. Ashwagandha may support stress-related hormonal issues while kisspeptin works on the direct signaling pathway.
  • Safe:DIM (Diindolylmethane) — Safe to use together. DIM helps with estrogen metabolism while kisspeptin focuses on GnRH/gonadotropin pathway.

Effectiveness

How do I know Kisspeptin-10 is working?

Moderate human trials · first signs hours to days 1-3

Evidence level

Moderate human trials

(Phase 1-2)

80/100

Regulatory status

Research compound

Onset of effects

Rapid

(hours to days)

How it works

Think of your reproductive system as a chain of dominoes.

Kisspeptin is the finger that tips the very first one. It's a small signaling molecule made in your brain's hypothalamus that tells special neurons to release GnRH (gonadotropin-releasing hormone).

[9][10] GnRH then tells your pituitary gland to release LH and FSH—the hormones that control your ovaries or testes. In men, this leads to testosterone production. [7] In women, it triggers egg development and ovulation.

Without kisspeptin, this whole cascade doesn't start—which is why people born without working kisspeptin signaling never go through puberty naturally [8].

The deeper mechanism

Kisspeptin-10 is the minimal bioactive fragment of the kisspeptin family, comprising the C-terminal 10 amino acids (residues 112-121) of the KISS1 gene product. [9] It acts as a potent agonist of the KISS1 receptor (GPR54), a G-protein coupled receptor expressed on GnRH neurons in the hypothalamus.

Binding activates Gq/11-mediated signaling, increasing intracellular calcium and depolarizing GnRH neurons. [9] This triggers pulsatile GnRH release into the hypophyseal portal system, subsequently stimulating pituitary gonadotroph cells to secrete LH and FSH.

[7][17] Kisspeptin neurons integrate metabolic, circadian, and stress signals, serving as a 'gatekeeper' for reproductive function. The KNDy (Kisspeptin-Neurokinin B-Dynorphin) neuron population in the arcuate nucleus generates the GnRH pulse generator signal.

[10] Kisspeptin-10's short half-life (~4 minutes IV) results from rapid proteolytic degradation, [14] though subcutaneous administration provides slightly extended exposure.

Unlike exogenous gonadotropins or GnRH analogs, kisspeptin triggers a physiological-pattern hormone release that more closely mimics natural reproductive physiology [13].

What to expect

  1. Hours to Days 1-3

    What you might notice

    • Rapid hormonal response—LH can rise within 30-60 minutes of injection [6]
    • Temporary flushing or feeling warm (this is the peptide working) [20]
    • In men: potential increase in morning erections within days
    • Mild injection site reactions that resolve quickly

    What's normal

    • Feeling warm or flushed for 30-60 minutes after injection
    • Minor injection site redness
    • Subtle energy or mood shifts as hormones adjust

    What's next

    • Keep off-periods between doses—intermittent dosing sustained the hormone response in studies where continuous dosing did not [18]
    • Track any effects in a simple log
    • Side effects typically stabilize after day 2-3
  2. Week 1-2

    What you might notice

    • Hormonal response depends on your dosing pattern—off-periods between doses kept it strong for 12 days in studies, while continuous or twice-daily dosing faded within days to two weeks [18][12]
    • Men may notice improved libido and sexual function
    • Women in fertility protocols may see measurable hormone changes on blood work [12]
    • Side effects like flushing typically decrease as your body adjusts

    What's normal

    • Settling into routine with milder side effects
    • Measurable changes in LH, FSH, and sex hormones on blood tests [7][12]
    • Improved sense of well-being related to hormone optimization

    What's next

    • Consider blood work to verify hormonal response
    • Adjust timing or dose based on response and goals
    • Continue tracking subjective effects
  3. Week 3-6

    What you might notice

    • With intermittent dosing, hormone responses were sustained through 12 days in studies—data beyond two weeks is limited [18]
    • In men: stable testosterone improvement with maintained fertility
    • Sustained improvements in sexual health and desire
    • Overall well-being related to optimized reproductive hormones

    What's normal

    • Consistent effects without further escalation
    • Stable hormone levels on blood work
    • Sexual health benefits maintained

    What's next

    • Evaluate whether to continue based on goals and blood work
    • Discuss protocol duration with healthcare provider
    • Consider cycling off or adjusting protocol as needed

Signs it's working

Hormonal Response (Men)

  • Improved morning erections returning
  • Enhanced libido and sexual desire
  • Blood work showing increased LH, FSH, and testosterone
  • Better energy and sense of vitality
  • Maintained or improved testicular size (unlike exogenous testosterone)

Hormonal Response (Women/Fertility)

  • Measurable LH and FSH increases on blood tests
  • In IVF: successful oocyte maturation without OHSS symptoms
  • Return of menstrual cycles in hypothalamic amenorrhea
  • Improved follicular development on ultrasound monitoring

Sexual Health Indicators

  • Increased interest in and anticipation of intimacy
  • Enhanced arousal responses
  • Improved satisfaction with sexual experiences
  • In men: improved erectile function
  • In women: enhanced brain processing of attraction and arousal [2]

Not seeing results? Common reasons

  • Dose too low—kisspeptin works quickly, but some people need more; consider gradual increase under guidance [6]
  • Wrong timing for goals—fertility protocols require cycle-specific timing that differs from general hormone optimization [11]
  • Underlying hypothalamic issues—severe hypothalamic dysfunction may need additional interventions beyond kisspeptin alone [16]
  • Interference from other hormones—exogenous testosterone or GnRH antagonists block kisspeptin's mechanism [17][22]
  • Poor quality peptide—always verify source with third-party testing certificates
  • Expecting indirect effects too quickly—sexual desire improvements may take longer than direct hormonal changes

Key research

2023[1]
“Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder”Mills EG, Ertl N, Wall MB, et al.Finding: This randomized clinical trial found that kisspeptin significantly enhanced brain activity in sexual processing regions and increased penile tumescence by up to 56% in men with low sexual desire. Participants also reported improved happiness about sex—suggesting kisspeptin could become the first pharmacological treatment for male HSDD.View study
2022[2]
“Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder”Thurston L, Hunjan T, Ertl N, et al.Finding: Kisspeptin modulated brain regions involved in sexual and facial attraction processing in women with HSDD. The effects correlated with reduced sexual aversion and improved responses to attractive stimuli, laying groundwork for potential female HSDD treatment.View study
2018[3]
“Clinical Parameters of Ovarian Hyperstimulation Syndrome Following Different Hormonal Triggers of Oocyte Maturation in IVF Treatment”Abbara A, Islam R, Clarke SA, et al.Finding: Compared to traditional hCG trigger, kisspeptin reduced ovarian volume by 3-fold and virtually eliminated OHSS symptoms. The odds of developing OHSS were 33x lower with kisspeptin compared to hCG, making it a much safer option for high-risk IVF patients.View study
2025[4]
“Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans”Mills EG, Thurston L, Yang L, et al.Finding: A placebo-controlled study of 95 participants confirmed that kisspeptin robustly stimulates LH release while having no effect on anxiety, cortisol, blood pressure, or heart rate. This provides reassurance that kisspeptin-based therapies won't cause psychological side effects.View study
2025[5]
“Intranasal Kisspeptin Administration Rapidly Stimulates Gonadotropin Release in Humans”Mills EG, Silva MSB, Delli V, et al.Finding: This breakthrough study showed that intranasal kisspeptin effectively stimulates LH release in healthy men, women, and patients with hypothalamic amenorrhea—without any adverse events. This non-invasive route could transform kisspeptin into a practical take-home treatment for reproductive disorders.View study
2011[6]
“Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men”George JT, Veldhuis JD, Roseweir AK, Newton CL, Faccenda E, Millar RP, Anderson RAFinding: IV bolus kisspeptin-10 across 0.01-3.0 mcg/kg produced dose-dependent LH rise; 1 mcg/kg gave maximal stimulation (peak LH 12.4 IU/L at 30 min), while 3 mcg/kg produced a reduced response.View study
2005[7]
“Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males”Dhillo WS, Chaudhri OB, Patterson M, et al.Finding: A 90-minute IV infusion of kisspeptin-54 in male volunteers significantly raised plasma LH (10.8 vs 4.2 U/L), FSH (3.9 vs 3.2 U/L) and testosterone (24.9 vs 21.7 nmol/L) compared with saline. Plasma half-life of kisspeptin-54 was 27.6 min.View study
2003[8]
“The GPR54 gene as a regulator of puberty”Seminara SB, Messager S, Chatzidaki EE, et al.Finding: Loss-of-function mutations in GPR54 — the kisspeptin receptor — cause autosomal recessive idiopathic hypogonadotropic hypogonadism, an absence of pubertal development, in humans; Gpr54-deficient mice show the same phenotype while remaining responsive to exogenous GnRH.View study
2001[9]
“The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54”Kotani M, Detheux M, Vandenbogaerde A, et al.Finding: Kisspeptins derived from the KiSS-1 gene product bind GPR54 with low-nanomolar affinity and stimulate PIP2 hydrolysis, Ca2+ mobilisation, arachidonic acid release and ERK1/2 and p38 MAP kinase phosphorylation — the Gq-coupled signalling arm of the receptor.View study
2010[10]
“Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion”Lehman MN, Coolen LM, Goodman RLFinding: Arcuate nucleus neurons co-expressing kisspeptin, neurokinin B and dynorphin (KNDy cells) are conserved from rodents to humans, form a reciprocally interconnected network projecting to GnRH cell bodies and terminals, and are positioned to serve as a component of the GnRH pulse generator; altered KNDy peptides are implicated in polycystic ovarian syndrome.View study
2007[11]
“Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women”Dhillo WS, Chaudhri OB, Thompson EL, et al.Finding: Subcutaneous bolus kisspeptin-54 raised plasma LH in every phase of the menstrual cycle, but the effect was far greatest in the preovulatory phase (mean LH rise 20.64 IU/L) and least in the follicular phase (0.12 IU/L).View study
2009[12]
“Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis”Jayasena CN, Nijher GMK, Chaudhri OB, et al.Finding: In women with hypothalamic amenorrhea, a single subcutaneous injection of kisspeptin-54 potently raised LH (+24.0 IU/L) and FSH (+9.1 IU/L); after 14 days of twice-daily injection the response had fallen to +2.5 and +0.5 IU/L, while responsiveness to GnRH was retained.View study
2015[13]
“Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy”Abbara A, Jayasena CN, Christopoulos G, et al.Finding: Phase 2 trial at Hammersmith Hospital (Imperial College London) in 60 women at high risk of OHSS, 37% of whom had PCOS. A single kisspeptin-54 injection produced oocyte maturation in 95% and live birth in 45% per transfer; no woman developed moderate, severe or critical OHSS, and kisspeptin-54 was well tolerated with no adverse events attributed to the injection.View study
2011[14]
“The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans”Jayasena CN, Nijher GMK, Comninos AN, et al.Finding: IV bolus kisspeptin-10 raised LH and FSH in men and in women during the preovulatory phase, but IV bolus, subcutaneous bolus and IV infusion all failed to raise gonadotropins in women during the follicular phase. Reported plasma half-life of kisspeptin-10 was approximately 3.8 minutes in men.View study
2007[15]
“Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosis-prone vessels”Mead EJ, Maguire JJ, Kuc RE, Davenport APFinding: GPR54 mRNA and protein were localised to vascular smooth muscle and endothelium of human aorta, coronary artery and umbilical vein, and kisspeptin-10, -13 and -54 all acted on isolated human vessel rings — establishing a direct action of kisspeptin on the human vasculature.View study
2014[16]
“Exogenous kisspeptin administration as a probe of GnRH neuronal function in patients with idiopathic hypogonadotropic hypogonadism”Chan YM, Lippincott MF, Butler JP, et al.Finding: Every subject with abiding idiopathic hypogonadotropic hypogonadism failed to mount a GnRH-induced LH response to an IV kisspeptin bolus that reliably produces one in healthy men and luteal-phase women; the one subject whose hypogonadotropism had reversed responded robustly.View study
2006[17]
“Repetitive activation of hypothalamic G protein-coupled receptor 54 with intravenous pulses of kisspeptin in the juvenile monkey (Macaca mulatta) elicits a sustained train of gonadotropin-releasing hormone discharges”Plant TM, Ramaswamy S, Dipietro MJFinding: Hourly IV kisspeptin-10 pulses evoked a sustained train of LH discharges in the juvenile monkey; concomitant treatment with the GnRH receptor antagonist acyline abolished kisspeptin-10-induced LH release, showing the response is wholly GnRH-dependent.View study
2026[18]
“Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men”Yeung AC, Phylactou M, Koysombat K, et al.Finding: Acute subcutaneous kisspeptin-10 infusion dose-dependently raised LH, FSH and testosterone in healthy men. Five days of continuous infusion left gonadotropins no different from vehicle, whereas daily intermittent dosing (8 h on, 16 h off) sustained the gonadotropin rise across 12 days.View study
2024[19]
“Administration of Kisspeptin in Patients With Hyperprolactinemia (NCT02956447) — posted results”Massachusetts General Hospital; ClinicalTrials.govFinding: Phase 2 study of kisspeptin 112-121 (kisspeptin-10) given intravenously (n=21) and subcutaneously (n=15). Posted adverse events include headache in 5/21 IV and 2/15 subcutaneous participants, dizziness in 1/21 and 1/15, and pain of skin in 3/21 and 2/15.View study
2026[20]
“Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism (NCT04648969) — posted results”Seminara SB; Massachusetts General Hospital; ClinicalTrials.govFinding: Phase 2 study of pulsatile kisspeptin 112-121 in hypogonadotropic hypogonadism (n=18). Posted adverse events include hot flashes (vascular disorders) in 1/18 and dizziness in 1/18.View study
2017[21]
“VIAGRA (sildenafil citrate) tablets — US prescribing information”Pfizer Laboratories Div Pfizer IncFinding: Mechanism of action: sildenafil inhibits PDE5, raising cGMP in the corpus cavernosum, producing smooth muscle relaxation and inflow of blood. The label states sildenafil at recommended doses has no effect in the absence of sexual stimulation.View study
2025[22]
“AZMIRO (testosterone cypionate) injection — US prescribing information”Azurity Pharmaceuticals, Inc.Finding: With large doses of exogenous androgens, spermatogenesis may be suppressed through feedback inhibition of the hypothalamic-pituitary-testicular axis and of pituitary FSH, with adverse effects on sperm count; the label notes reduced fertility in some men on testosterone replacement therapy and reports of testicular atrophy, subfertility and infertility.View study
1997[23]
“Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity”Pruessner JC, Wolf OT, Hellhammer DH, et al.Finding: Salivary free cortisol rises sharply in the period immediately after awakening — the cortisol awakening response — and this post-waking rise is a stable, reproducible marker of adrenocortical activity within individuals.View study

Clinical trials

Kisspeptin-10 tested in people

33 registered studies, 5 still enrolling.

33registered studies
5recruiting now
3phase 3 or 4
9with published results

By phase

Phase 111
Phase 25
Phase 33
No phase14

A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.

What kind of research

Gave the drug29
Records only4

About 1,718 people took part in the studies that actually administered Kisspeptin-10. Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.

Most recent

  • ISRCTN9658642044 enrolled

    Investigating how a natural hormone called kisspeptin affects social and emotional brain processing

    Imperial College London

  • NCT07224490Phase 1Recruiting40 enrolled

    Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease

    Stephanie B. Seminara, MD

  • NCT07224438Phase 2Recruiting20 enrolled

    Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea

    Stephanie B. Seminara, MD

See all 33 trials for Kisspeptin-10

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when Kisspeptin-10 is named as an intervention; studies that only mention it in passing are not.

Questions

Frequently asked about Kisspeptin-10

How is kisspeptin different from testosterone replacement therapy?

They work in completely opposite directions! Testosterone replacement therapy (TRT) gives you hormones from outside your body, which tells your brain to stop making its own—eventually shrinking your testicles and making you dependent on injections. [22] Kisspeptin does the opposite: it tells your brain to make MORE of your natural hormones. Your body keeps producing testosterone itself, maintaining fertility and testicular function [6][7].

Can kisspeptin help with fertility in men?

Yes, and this is one of its key advantages. Unlike testosterone or even HCG alone, kisspeptin stimulates the natural hormone cascade that supports sperm production. It increases both LH (which stimulates testosterone) and FSH (which is essential for sperm development). [7][18] Men trying to conceive can use kisspeptin to optimize hormones without compromising fertility.

Why is kisspeptin being studied for IVF?

Traditional IVF uses hCG to trigger egg maturation, but this carries risk of ovarian hyperstimulation syndrome (OHSS)—a potentially dangerous condition where ovaries swell dramatically. Studies show kisspeptin triggers egg maturation just as effectively while reducing OHSS risk by over 30-fold. [3][13] It's especially promising for women with PCOS or many follicles who are at highest OHSS risk [13].

Will kisspeptin work if I have low testosterone from aging?

It depends on what's causing your low testosterone. If your hypothalamus and pituitary still respond normally (they're just not being stimulated enough), kisspeptin can help by kickstarting the signaling. If there's damage or dysfunction in the hypothalamus or pituitary (like from tumors or injury), kisspeptin may be less effective. [16] Blood work before and during use can help determine response.

Is kisspeptin the same as Viagra for sexual function?

No, they work completely differently. Viagra affects blood flow to enable erections but doesn't change desire. [21] Kisspeptin works in the brain to enhance sexual desire, attraction, and arousal at the neurological level. In clinical trials, it improved both the mental aspects (wanting sex, happiness about sex) AND physical responses (penile tumescence). [1][2] They target different parts of the sexual experience.

Can women use kisspeptin?

Absolutely. Research shows kisspeptin affects women powerfully, though responses vary with menstrual cycle phase. During the pre-ovulatory phase, kisspeptin stimulates the LH surge needed for ovulation. [11][14] It's being studied for treating hypothalamic amenorrhea (lost periods from stress/low weight), PCOS, and as a safer IVF trigger. [12][13] It also enhanced brain processing of attraction in women with low sexual desire [2].

Why does kisspeptin cause flushing?

Kisspeptin has effects beyond just the reproductive system—it also influences blood vessels. [15] The flushing you feel is related to temporary blood vessel dilation. This is actually similar to what happens naturally during sexual arousal (blushing, feeling warm). It's a sign the peptide is working, and the effect typically fades within 30-60 minutes and becomes less noticeable with continued use.

Is kisspeptin FDA approved?

No, kisspeptin is currently a research compound undergoing clinical trials [19][20]—it's not FDA approved for any indication yet. Most research has been conducted at Imperial College London and other major research centers. [1][13] The results are promising, especially for IVF and sexual health disorders, but it hasn't completed the approval process. It's available only for research purposes.

What is the typical Kisspeptin-10 dosage schedule?

Research protocols typically start at 50mcg injected subcutaneously once daily, moving to the standard 100mcg once daily after tolerance is established. Advanced protocols run 100–200mcg once or twice daily. Dosing is usually cycled rather than continuous, [18] and fertility-focused protocols may time doses to cycle phase — see the dosing protocol page for full schedules and adjustment guidance. (Clinical research settings have also used single 1mcg/kg IV boluses, [6] but subcutaneous dosing is the standard research route.)

What are the side effects of Kisspeptin-10?

The most commonly reported effects are mild: flushing or a feeling of warmth (covered in more detail in the flushing FAQ above), injection-site reactions, and mild headache. [19][20] Less commonly, a temporary increase in heart rate or brief dizziness has been reported. [19][20] As with any peptide, allergic reaction is the serious one to watch for — discontinue and seek medical care for difficulty breathing or significant swelling. The safety section below covers management for each.

When is the best time to take Kisspeptin-10?

Morning administration works well for most goals — it aligns with the body's natural cortisol awakening response [23] and gives hormones time to rise during active hours. Food timing doesn't matter; absorption isn't significantly affected by meals, so consistency beats clock-perfection. The exception is fertility-focused protocols, where timing may be adjusted to cycle phase [11][14] — covered in the dosing protocol.

Further reading

Kisspeptin-10 history & related research

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Kisspeptin-10, on one page.

Medical disclaimer

Kisspeptin-10 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 9, 2026